Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters










Publication year range
1.
J Vet Intern Med ; 34(5): 2091-2095, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32681715

ABSTRACT

A 7-year-old castrated male French Bulldog was examined for chronic large intestinal enteropathy. A colonic mass and thickened rectal mucosa were identified, and histopathologic examination of endoscopic biopsy specimens disclosed eosinophilic proctitis with large (5-20 µm), irregularly shaped, pauciseptate hyphae that were Gomori methenamine silver and periodic acid-Schiff positive. Amplification and sequencing of ribosomal DNA extracted from paraffin-embedded tissues yielded a sequence with 97% identity to GenBank sequences for Basidiobolus ranarum. After itraconazole, terbinafine, and prednisone administration, clinical signs resolved rapidly, and sonographic lesions were largely absent after 6 weeks. Treatment was discontinued by the owner 15 weeks after diagnosis. Three weeks later, the dog collapsed acutely and was euthanized. Necropsy identified metastatic islet cell carcinoma and grossly unremarkable colorectal tissues. However, histopathology of the rectum disclosed multifocal submucosal granulomas with intralesional hyphae morphologically similar to those previously observed. This report is the first to describe medical treatment of gastrointestinal basidiobolomycosis in a dog.


Subject(s)
Colorectal Neoplasms , Dog Diseases , Entomophthorales , Zygomycosis , Animals , Colorectal Neoplasms/veterinary , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Dogs , Male , Zygomycosis/diagnosis , Zygomycosis/drug therapy , Zygomycosis/veterinary
2.
J Am Anim Hosp Assoc ; 56(3): e56304, 2020.
Article in English | MEDLINE | ID: mdl-32182118

ABSTRACT

A 10 wk old female border collie was presented for hemorrhagic diarrhea and pelvic limb lameness. Examination revealed pain and effusion in multiple appendicular joints and pyrexia. Clinicopathologic testing revealed moderate neutropenia as well as nondegenerate neutrophilic inflammation in multiple joints. Radiographs showed capsular joint swelling and heterogeneous metaphyseal lucencies in the distal radius, ulna, femur, and tibia. Genetic testing confirmed a mutation in the vacuolar protein sorting-associated protein 13B gene and a diagnosis of trapped neutrophil syndrome (TNS). Within 24 hr of initiating prednisone therapy (1 mg/kg, per os, q 12 hr), the dog was afebrile and nonpainful with normal ambulation. Lameness recurred twice over the next 5 mo. At 9 mo of age, diagnostics showed severe erosive polyarthritis of both stifles with an inflammatory leukogram and arthrocentesis findings consistent with septic arthritis, and the dog died despite antibiotic therapy. This is the first case of TNS described in the North American literature, and it is unique in that we had the opportunity to document progression of radiographic abnormalities over more than 6 mo. TNS should be considered in young border collies with signs suggestive of immune-mediated polyarthritis, septic arthritis, or hypertrophic osteodystrophy, combined with neutropenia or gastrointestinal signs.


Subject(s)
Arthritis/veterinary , Dog Diseases/diagnosis , Neutropenia/veterinary , Animals , Arthritis/complications , Arthritis/diagnosis , Arthritis/genetics , Diagnosis, Differential , Dog Diseases/diagnostic imaging , Dogs , Female , Lameness, Animal/etiology , Neutropenia/complications , Neutropenia/diagnosis , Neutropenia/genetics , Pedigree , Vesicular Transport Proteins/genetics
4.
J Vet Intern Med ; 33(3): 1434-1439, 2019 May.
Article in English | MEDLINE | ID: mdl-31004383

ABSTRACT

Gastrointestinal (GI) pythiosis is a severe and often fatal disease in dogs that traditionally has been poorly responsive to medical treatment. Although aggressive surgical resection with wide margins is the most consistently effective treatment, lesion location and extent often preclude complete resection. Recently, it has been suggested that the addition of anti-inflammatory doses of corticosteroids may improve outcome in dogs with nonresectable GI pythiosis. This report describes 3 dogs with colonic pythiosis in which complete resolution of clinical signs, regression of colonic masses, and progressive decreases in serological titers were observed after treatment with itraconazole, terbinafine, and corticosteroids. This treatment protocol represents a promising treatment for dogs with GI pythiosis in which surgical intervention is not feasible.


Subject(s)
Dog Diseases/drug therapy , Itraconazole/therapeutic use , Prednisone/therapeutic use , Pythiosis/drug therapy , Terbinafine/therapeutic use , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Colon/pathology , Dog Diseases/microbiology , Dogs , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/microbiology , Gastrointestinal Diseases/veterinary , Itraconazole/administration & dosage , Prednisone/administration & dosage , Pythium/immunology , Serologic Tests/veterinary , Terbinafine/administration & dosage
5.
J Am Anim Hosp Assoc ; 54(6): 327-337, 2018.
Article in English | MEDLINE | ID: mdl-30272479

ABSTRACT

Opportunistic fungal infections have long been recognized as rare causes of disease in immunocompetent dogs and cats. Recently, the escalating use of multiagent immunosuppression protocols (especially those that include cyclosporine) has resulted in an increased number of patients with opportunistic fungal infection encountered by small animal practitioners and has altered the typical case phenotype. Based on histologic and cytologic features such as pigmentation, hyphal diameter, and distribution in tissue, these opportunistic mycoses can be placed into categories such as phaeohyphomycosis, hyalohyphomycosis, and eumycotic mycetoma. This review aims to summarize the clinical presentations, methods for diagnosis, treatment recommendations, and prognosis for both immunocompetent and immunosuppressed patients with opportunistic fungal infections. An example case description is included to illustrate the most common current clinical presentation.


Subject(s)
Cat Diseases , Dog Diseases , Mycoses/veterinary , Opportunistic Infections/veterinary , Animals , Antifungal Agents/therapeutic use , Body Size , Cat Diseases/chemically induced , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Cats , Dog Diseases/chemically induced , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Dogs , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Mycoses/diagnosis , Mycoses/drug therapy , Opportunistic Infections/diagnosis , Opportunistic Infections/drug therapy , Prognosis
6.
Am J Vet Res ; 79(11): 1160-1165, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30372150

ABSTRACT

OBJECTIVE To evaluate the effect of an immunotherapeutic product on concentrations of anti-Pythium insidiosum antibodies in dogs. ANIMALS 7 healthy hound-crossbreds. PROCEDURES Antibody concentrations were evaluated before (day 0) and after administration of the immunotherapeutic product. The immunotherapeutic product was administered on days 0, 7, and 21. Serum was obtained on days 0, 7, 14, 21, 28, 35, 42, 49, and 56. Anti-P insidiosum antibody concentrations were measured and reported as the percentage positivity relative to results for a strongly positive control serum. RESULTS Mean ± SD percentage positivity before administration of the immunotherapeutic product was 7.45 ± 3.02%. There was no significant change in anti-P insidiosum antibody concentrations after administration of the product, with percentage positivity values in all dogs remaining within the range expected for healthy dogs (3% to 15%). CONCLUSIONS AND CLINICAL RELEVANCE Administration of the immunotherapeutic product to healthy dogs in accordance with the manufacturer's suggested protocol did not induce a significant change in anti-P insidiosum antibody concentrations. These results suggested that administration of the immunotherapeutic product may not interfere with postadministration serologic monitoring. However, further investigations will be required to determine whether there is a similar effect in naturally infected dogs.


Subject(s)
Antibodies/blood , Dog Diseases/prevention & control , Immunotherapy/veterinary , Pythium/immunology , Animals , Dogs , Female
7.
Fungal Biol ; 120(8): 931-947, 2016 08.
Article in English | MEDLINE | ID: mdl-27521626

ABSTRACT

Over the past twenty years, infections caused by previously unrecognised oomycete pathogens with morphological and molecular similarities to known Lagenidium species have been observed with increasing frequency, primarily in dogs but also in cats and humans. Three of these pathogens were formally described as Lagenidium giganteum forma caninum, Lagenidium deciduum, and Paralagenidium karlingii in advance of published phylogenetic verification. Due to the complex nature of Lagenidium taxonomy alongside recent reports of mammalian pathogenic species, these taxa needed to be verified with due consideration of the available data for Lagenidium and its allied genera. This study does so through morphologic characterisation of the mammalian pathogenic species, and phylogenetic analyses. The six-gene phylogeny generally supports the most recent comprehensive classification of Lagenidium with a well-supported Lagenidium clade that includes the mammalian pathogens L. giganteum f. caninum and L. deciduum, and well-supported clades for which the names Myzocytiopsis and Salilagenidium can be applied. The genus Paralagenidium is phylogenetically unrelated to any of the main clades within the class Peronosporomycetes. Close relationships between pathogens of mammals and those of insects or nematodes were revealed. Further characterisation of Lagenidium-like taxa is needed to establish the risk of mammalian infection by pathogens of insects and nematodes.


Subject(s)
Lagenidium/classification , Lagenidium/isolation & purification , Mycoses/microbiology , Mycoses/veterinary , Phylogeny , Animals , Cats , Cluster Analysis , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Dogs , Fungal Proteins/genetics , Genes, rRNA , Humans , Lagenidium/cytology , Lagenidium/genetics , Microscopy , Mitochondrial Proteins/genetics , RNA, Fungal/genetics , RNA, Ribosomal/genetics , Sequence Analysis, DNA
8.
Med Mycol ; 54(6): 641-7, 2016 Aug 01.
Article in English | MEDLINE | ID: mdl-27118800

ABSTRACT

Pythiosis is a life-threatening infectious disease of both humans and animals living in Asia, Americas, Africa, and parts of Australia and New Zealand. The etiologic pathogen is the fungus-like organism Pythium insidiosum The disease has high mortality and morbidity rates. Use of antifungal drugs are ineffective against P. insidiosum, leaving radical surgery the main treatment option. Prompt treatment leads to better prognosis of affected individuals, and could be achieved by early and accurate diagnosis. Since pythiosis has been increasingly reported worldwide, there is a need for a rapid, user-friendly, and efficient test that facilitates the diagnosis of the disease. This study aims to develop an immunochromatographic test (ICT), using the bacterial protein A/G, to detect anti-P. insidiosum IgGs in humans and animals, and compare its diagnostic performance with the established ELISA. Eighty-five serum samples from 28 patients, 24 dogs, 12 horses, 12 rabbits, and 9 cattle with pythiosis, and 143 serum samples from 80 human and 63 animal subjects in a healthy condition, with thalassemia, or with other fungal infections, were recruited for assay evaluation. Detection specificities of ELISA and ICT were 100.0%. While the detection sensitivity of ELISA was 98.8%, that of ICT was 90.6%. Most pythiosis sera, that were falsely read negative by ICT, were weakly positive by ELISA. In conclusion, a protein A/G-based ICT is a rapid, user-friendly, and efficient assay for serodiagnosis of pythiosis in humans and animals. Compared to ELISA, ICT has an equivalent detection specificity and a slightly lower detection sensitivity.


Subject(s)
Antibodies, Fungal/blood , Chromatography, Affinity/methods , Pythiosis/diagnosis , Pythium/immunology , Serologic Tests/methods , Americas , Animals , Asia , Blood Donors , Cattle , Dogs , Enzyme-Linked Immunosorbent Assay , Horses , Humans , Immunoglobulin G/blood , Rabbits , Sensitivity and Specificity
9.
J Vet Cardiol ; 17(2): 142-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26003903

ABSTRACT

Fungal disease is a rare cause of pericardial effusion in dogs. This report describes the first case of fungal pericardial effusion and myocarditis secondary to the fungal organism Inonotus tropicalis. A 9-year-old female spayed French bulldog with a multi-year history of treatment with glucocorticoids for management of atopy was presented for exercise intolerance, ascites and weight loss. Physical examination and thoracic imaging revealed enlarged peripheral and cranial mediastinal lymph nodes, left ventricular thickening and cardiac tamponade secondary to pericardial effusion. Fine needle aspiration of the cranial mediastinal lymph node showed pyogranulomatous inflammation with short, thin and poorly septated hyphae. Culture of the aspirate yielded a fungal isolate identified as Inonotus tropicalis based on morphologic features and rRNA gene sequencing. Postmortem examination showed myocardial thickening with multifocal to coalescing, firm, white, ill-defined nodules. Histology confirmed the presence of disseminated fungal infection with extensive myocardial involvement. Inonotus tropicalis is an opportunistic poroid wood-decaying basidiomycete. Infection in this dog was likely the result of chronic immunosuppressive therapy.


Subject(s)
Dog Diseases/diagnosis , Mycoses/veterinary , Myocarditis/veterinary , Pericardial Effusion/veterinary , Animals , Basidiomycota/isolation & purification , Dog Diseases/diagnostic imaging , Dogs , Echocardiography , Fatal Outcome , Female , Mycoses/complications , Mycoses/diagnosis , Myocarditis/complications , Myocarditis/diagnosis , Pericardial Effusion/etiology
11.
Vet Dermatol ; 25(1): 52-e21, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24372864

ABSTRACT

BACKGROUND: Pythium insidiosum is an oomycete that causes cutaneous lesions or infiltrative gastrointestinal disease in dogs, cats, humans, horses and other mammals, primarily in tropical and subtropical climates. HYPOTHESIS/OBJECTIVES: We report the clinicopathological findings associated with cutaneous pythiosis in two dogs from a Northern temperate climate zone. ANIMALS: A 3-year-old intact male Chesapeake Bay retriever was presented with an ulcerated soft-tissue swelling over the left eye. A 4-year-old spayed female German shepherd dog was presented with a soft-tissue swelling overlying the right hock. Both dogs lived in northern latitudes (between 43 and 45°N) and neither had travelled outside of Wisconsin or Michigan's upper peninsula, USA. METHODS: Histopathological examination and culture of affected tissues on specialized media, serology for anti-P. insidiosum antibodies, P. insidiosum-specific PCR and ribosomal RNA gene sequencing were carried out. RESULTS: Histopathological examination revealed pyogranulomatous and eosinophilic inflammation associated with wide, poorly septate hyphae. CONCLUSIONS AND CLINICAL IMPORTANCE: Even clinicians who practice in temperate climates should consider pythiosis as a differential diagnosis for young to middle-aged adult dogs presented with ulcerated cutaneous nodules or infiltrative gastrointestinal disease.


Subject(s)
Dog Diseases/microbiology , Pythiosis/veterinary , Pythium/isolation & purification , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Dog Diseases/diagnosis , Dog Diseases/epidemiology , Dog Diseases/pathology , Dogs , Female , Immunotherapy/veterinary , Itraconazole/administration & dosage , Itraconazole/therapeutic use , Male , Molecular Sequence Data , Naphthalenes/administration & dosage , Naphthalenes/therapeutic use , Prednisone/therapeutic use , Pythiosis/diagnosis , Pythiosis/epidemiology , Pythiosis/pathology , Pythium/genetics , RNA, Ribosomal/genetics , Terbinafine , Wisconsin/epidemiology
13.
Vet Clin Pathol ; 41(3): 419-23, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22747656

ABSTRACT

A 4-year-old male neutered Labrador Retriever with severe gastrointestinal signs, but no respiratory signs, was diagnosed with multifocal pyogranulomatous gastritis, enteritis, and lymphadenitis with intralesional hyphae and multifocal pyogranulomatous pneumonia with intralesional yeast. Based on cytologic evaluation, histologic examination with special stains, and immunohistochemical analysis of tissues collected antemortem or at necropsy, dual infections with Pythium insidiosum and Blastomyces dermatitidis were detected and are reported for the first time.


Subject(s)
Blastomyces/isolation & purification , Blastomycosis/veterinary , Dog Diseases/pathology , Pneumonia/veterinary , Pythiosis/veterinary , Pythium/isolation & purification , Animals , Biopsy, Fine-Needle , Blastomycosis/complications , Blastomycosis/microbiology , Blastomycosis/pathology , Dog Diseases/microbiology , Dog Diseases/parasitology , Dogs , Duodenum/parasitology , Duodenum/pathology , Enteritis/complications , Enteritis/parasitology , Enteritis/pathology , Enteritis/veterinary , Gastritis/complications , Gastritis/parasitology , Gastritis/pathology , Gastritis/veterinary , Hyphae , Lung/microbiology , Lymph Nodes/parasitology , Lymph Nodes/pathology , Lymphadenitis/complications , Lymphadenitis/parasitology , Lymphadenitis/pathology , Lymphadenitis/veterinary , Male , Pneumonia/complications , Pneumonia/microbiology , Pneumonia/pathology , Prognosis , Pythiosis/complications , Pythiosis/parasitology , Pythiosis/pathology , Stomach/parasitology , Yeasts
14.
Med Mycol ; 50(5): 509-12, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22122265

ABSTRACT

A bone marrow infection caused by Phialosimplex caninus was diagnosed in a seven-year-old female spayed Cocker Spaniel that was receiving prednisone for autoimmune hemolytic anemia. Histopathologic examination of a bone marrow core biopsy revealed clusters of oval to round yeast-like cells of varying shape and size and occasional irregular hyphae. Culture of a bone marrow aspirate sample yielded a mould initially suggestive of Paecilomyces inflatus or Sagenomella species but later determined to be P. caninus. The dog was treated with itraconazole and amphotericin B, and prednisone was continued at the lowest dose needed to control the hemolytic anemia. The patient died after 18 months of treatment. This is the first detailed clinical report of infection caused by P. caninus, a newly described fungus associated with disseminated disease in dogs.


Subject(s)
Eurotiales/isolation & purification , Immunocompromised Host , Myelitis/microbiology , Amphotericin B/therapeutic use , Animals , Antifungal Agents/therapeutic use , Dogs , Eurotiales/classification , Fatal Outcome , Female , Itraconazole/therapeutic use , Myelitis/diagnosis , Myelitis/drug therapy
15.
J Am Vet Med Assoc ; 239(9): 1232-5, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21999797

ABSTRACT

CASE DESCRIPTION: A 4-year-old spayed female Boxer was evaluated for a cutaneous mass located on the dorsum. The mass had been present for 6 weeks and was increasing in size. CLINICAL FINDINGS: A mass of approximately 10 cm in diameter was detected on the dorsum cranial to the right ilial wing. Histologic examination of a tissue sample from the mass led to the diagnosis of cutaneous pythiosis. Computed tomography of the abdomen and the mass were performed and revealed a contrast-enhancing soft tissue mass of the dorsum and enlarged intra-abdominal lymph nodes. TREATMENT AND OUTCOME: The dog underwent surgical excision of the cutaneous mass, including 5-cm skin margins and deep margins of 2 fascial planes. The mass was completely excised on the basis of results of histologic examination of surgical margins. The dog received itraconazole and terbinafine by mouth for 3 months following surgery. Recheck examination at 20 months postoperatively showed no signs of recurrence of pythiosis at the surgical site. CLINICAL RELEVANCE: Aggressive surgical excision in combination with medical treatment resulted in a favorable long-term (> 1 year) outcome in this dog. Thorough workup including diagnostic imaging and lymph node evaluation is recommended. If surgery is to be performed, skin margins of 5 cm and deep margins of 2 fascial planes are recommended.


Subject(s)
Dog Diseases/therapy , Pythiosis/veterinary , Animals , Antibodies/blood , Antifungal Agents/therapeutic use , Dog Diseases/blood , Dog Diseases/diagnosis , Dog Diseases/immunology , Dogs , Female , Itraconazole/therapeutic use , Naphthalenes/therapeutic use , Pythiosis/diagnosis , Pythiosis/immunology , Pythiosis/therapy , Pythium/isolation & purification , Terbinafine
16.
J Am Vet Med Assoc ; 238(2): 183-8, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-21235371

ABSTRACT

OBJECTIVE: To assess patterns of seroreactivity to Leptospira serovars in veterinary professional staff and dog owners exposed to dogs with acute leptospirosis and to contrast these patterns in people with those observed in dogs. DESIGN: Cross-sectional study. SAMPLE POPULATION: Human subjects consisted of 91 people (50 veterinarians, 19 technical staff, 9 administrative personnel, and 13 dog owners) exposed to dogs with leptospirosis. Canine subjects consisted of 52 dogs with naturally occurring leptospirosis admitted to the University of Bern Vetsuisse Faculty Small Animal Clinic in 2007 and 2008. PROCEDURES: People were tested for seroreactivity to regionally prevalent Leptospira serovars by use of a complement fixation test. A questionnaire designed to identify risk factors associated with seropositivity was used to collect demographic information from each study participant. Dogs were tested for seroreactivity to Leptospira serovars by use of a microscopic agglutination test. RESULTS: On the basis of microscopic agglutination test results, infected dogs were seropositive for antibodies against Leptospira serovars as follows (in descending order): Bratislava (43/52 [83%]), Australis (43/52 [83%]), Grippotyphosa (18/52 [35%]), Pomona (12/52 [23%]), Autumnalis (6/52 [12%]), Icterohemorrhagiae (4/52 [8%]), Tarassovi (2/52 [4%]), and Canicola (1/52 [2%]). All 91 people were seronegative for antibodies against Leptospira serovars. Therefore, statistical evaluation of risk factors and comparison of patterns of seroreactivity to Leptospira serovars between human and canine subjects were limited to theoretical risks. CONCLUSIONS AND CLINICAL RELEVANCE: Seroreactivity to Leptospira serovars among veterinary staff adhering to standard hygiene protocols and pet owners exposed to dogs with acute leptospirosis was uncommon.


Subject(s)
Dog Diseases/microbiology , Hospitals, Animal , Leptospira/classification , Leptospirosis/veterinary , Veterinarians , Zoonoses/microbiology , Agglutination Tests , Animals , Antibodies, Bacterial/blood , Dog Diseases/blood , Dog Diseases/immunology , Dog Diseases/transmission , Dogs , Humans , Leptospirosis/blood , Leptospirosis/immunology , Leptospirosis/transmission , Risk Factors
17.
Med Mycol ; 49(5): 539-42, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21174493

ABSTRACT

Medical therapy for pythiosis is hampered by a lack of efficacious drugs. The present report describes a case of canine gastrointestinal pythiosis in which lesions were resolved through the administration of itraconazole, terbinafine, and the agricultural fungicide mefenoxam. No substantial adverse effects occurred in association with administration of the latter compound. Additional studies are needed to evaluate the pharmacokinetics of mefenoxam and to further assess its tolerability and potential efficacy for the treatment of pythiosis in dogs.


Subject(s)
Antifungal Agents/administration & dosage , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Gastrointestinal Diseases/veterinary , Pythiosis/veterinary , Pythium/isolation & purification , Alanine/administration & dosage , Alanine/adverse effects , Alanine/analogs & derivatives , Animals , Antifungal Agents/adverse effects , Dogs , Duodenum/pathology , Female , Gastrointestinal Diseases/diagnosis , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/pathology , Histocytochemistry , Itraconazole/administration & dosage , Itraconazole/adverse effects , Naphthalenes/administration & dosage , Naphthalenes/adverse effects , Pythiosis/diagnosis , Pythiosis/drug therapy , Pythiosis/pathology , Terbinafine , Treatment Outcome
18.
Am J Vet Res ; 71(4): 460-7, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20367055

ABSTRACT

OBJECTIVE: To determine the pharmacokinetics and safety of voriconazole administered orally in single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis). ANIMALS: 15 clinically normal adult Hispaniolan Amazon parrots. PROCEDURES: Single doses of voriconazole (12 or 24 mg/kg) were administered orally to 15 and 12 birds, respectively; plasma voriconazole concentrations were determined at intervals via high-pressure liquid chromatography. In a multiple-dose trial, voriconazole (18 mg/kg) or water was administered orally to 6 and 4 birds, respectively, every 8 hours for 11 days (beginning day 0); trough plasma voriconazole concentrations were evaluated on 3 days. Birds were monitored daily, and clinicopathologic variables were evaluated before and after the trial. RESULTS: Voriconazole elimination half-life was short (0.70 to 1.25 hours). In the single-dose experiments, higher drug doses yielded proportional increases in the maximum plasma voriconazole concentration (C(max)) and area under the curve (AUC). In the multiple-dose trial, C(max), AUC, and plasma concentrations at 2 and 4 hours were decreased on day 10, compared with day 0 values; however, there was relatively little change in terminal half-life. With the exception of 1 voriconazole-treated parrot that developed polyuria, adverse effects were not evident. CONCLUSIONS AND CLINICAL RELEVANCE: In Hispaniolan Amazon parrots, oral administration of voriconazole was associated with proportional kinetics following administration of single doses and a decrease in plasma concentration following administration of multiple doses. Oral administration of 18 mg of voriconazole/kg every 8 hours would require adjustment to maintain therapeutic concentrations during long-term treatment. Safety and efficacy of voriconazole treatment in this species require further investigation.


Subject(s)
Amazona/metabolism , Antifungal Agents/pharmacokinetics , Pyrimidines/pharmacokinetics , Triazoles/pharmacokinetics , Administration, Oral , Animals , Antifungal Agents/administration & dosage , Antifungal Agents/adverse effects , Antifungal Agents/blood , Area Under Curve , Drug Administration Schedule , Half-Life , Pyrimidines/administration & dosage , Pyrimidines/adverse effects , Pyrimidines/blood , Triazoles/administration & dosage , Triazoles/adverse effects , Triazoles/blood , Voriconazole
19.
Am J Vet Res ; 69(11): 1463-8, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18980428

ABSTRACT

OBJECTIVE: To evaluate the radial growth assay for use in in vitro susceptibility testing of Pythium insidiosum and a Lagenidium sp and to assess susceptibility of representative isolates to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam. SAMPLE POPULATION: 6 isolates each of P insidiosum and Lagenidium sp. PROCEDURES: Isolates were plated in triplicate onto agar supplemented with antifungal compounds at concentrations of 0.025 to 8 microg/mL. Isolates on dimethyl sulfoxide- and water-supplemented agar served as control samples. Effect of antifungal concentration on colony diameter was assessed with a mixed linear model. Assay variability was assessed with the coefficient of variation. RESULTS: Colony growth was uniform (mean intra-assay and interassay coefficients of variation were < 5%). Minimal inhibition was evident with voriconazole and posaconazole at 8 microg/mL. Terbinafine at 8 microg/mL significantly reduced growth of P insidiosum and at > or = 1 microg/mL significantly reduced growth of the Lagenidium sp. Caspofungin and mefenoxam (concentrations > or = 1 microg/mL and > or = 0.025 microg/mL, respectively) significantly reduced growth of both pathogens. Mefenoxam at 0.1 microg/mL caused > 50% growth inhibition in 11 of 12 isolates and at 1 microg/mL caused > 90% inhibition in all isolates. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that the radial growth assay was a simple, reproducible technique for susceptibility testing of P insidiosum and a Lagenidium sp. Azoles had limited activity, whereas terbinafine and caspofungin caused significant but minimal to moderate inhibition. Only mefenoxam had a profound effect on both pathogens at concentrations likely to be achievable in tissues.


Subject(s)
Anti-Infective Agents/pharmacology , Lagenidium/drug effects , Pythium/drug effects , Alanine/analogs & derivatives , Alanine/pharmacology , Caspofungin , Echinocandins/pharmacology , In Vitro Techniques , Itraconazole/pharmacology , Lagenidium/growth & development , Lipopeptides , Microbial Sensitivity Tests , Naphthalenes/pharmacology , Pyrimidines/pharmacology , Pythium/growth & development , Terbinafine , Triazoles/pharmacology , Voriconazole
20.
Vet Dermatol ; 19(6): 391-4, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18699814

ABSTRACT

An 18-year-old Arabian mare was examined with a large mass on the left hind pastern and fetlock. The mare was located in the Central Valley of northern California, and had never been out of the state. Routine histopathological processing and examination of biopsy samples from the mass showed several hyphal organisms that were delineated with a silver stain. Using immunohistochemistry the organism was diagnosed as Pythium insidiosum. The owner declined debulking surgery, and despite treatment with an immunotherapeutic vaccine, the horse's condition deteriorated leading to euthanasia.


Subject(s)
Horse Diseases/therapy , Immunotherapy/veterinary , Pythium/isolation & purification , Skin Diseases/veterinary , Vaccines/therapeutic use , Animals , Female , Horse Diseases/microbiology , Horse Diseases/pathology , Horses , Skin Diseases/microbiology , Skin Diseases/pathology , Skin Diseases/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...